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Muscarinic acetylcholine receptor (mAChR) III expressed in Xenopus oocytes, like mAChR I, mediates activation of a 
Ca2 +-dependent Cl- current, whereas mAChR IV, like mAChR II, principally induces activation of Na+ and K + cur- 
rents in a Ca2+-independent manner. mAChR III has a sensitivity to agonist of about one order of magnitude higher 
than that of mAChR I in mediating the Ca 2 +-dependent current response in Xenopus oocytes and in stimulating phos- 
phoinositide hydrolysis in NGl08-15 neuroblastoma-glioma hybrid cells. The agonist-binding affinity of mAChR III is 
also about one order of magnitude higher than that of mAChR I. 
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1. INTRODUCTION 
An effective approach to studying the functional 
heterogeneity of the muscarinic acetylcholine 
receptor (mAChR) has been provided by expres- 
sion of cloned DNAs encoding molecularly distinct 
mAChR subtypes. The antagonist-binding proper- 
ties of four individual mAChR subtypes expressed 
in Xenopus oocytes [l-3] indicate that mAChR I, 
mAChR II and mAChR III correspond most close- 
ly to the pharmacologically defined Mi (I), MZ car- 
diac (II) and MZ glandular (III) subtypes [4-61, 
respectively. Hybridization analysis has shown 
that the mRNAs encoding the four mAChR sub- 
types are differentially distributed in tissues, that 
is, the mAChR II mRNA in heart [7-91, both 
mAChR II and mAChR III mRNAs in smooth 
muscles [9], both mAChR I and mAChR III 
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mRNAs in exocrine glands [9] and all four 
mAChR mRNAs in cerebrum [1,7-lo]. Thus, the 
mAChR heterogeneity in tissues with respect o an- 
tagonist binding can be accounted for by the 
presence of individual molecularly distinct 
mAChR subtypes or various combinations of 
them. Furthermore, DNA expression studies with 
Xenopus oocytes and mammalian cells have 
revealed that mAChR subtypes are selectively 
coupled with different effector systems, albeit not 
exclusively. Initially, evidence has been obtained to 
indicate that mAChR I expressed in Xenopus 
oocytes mediates activation of a Cat+-dependent 
Cl- current, whereas mAChR II principally in- 
duces activation of Na+ and K+ currents in a 
Ca’+-independent manner [ 1,2]. Expression 
studies in mammalian cells have further shown 
that mAChR I and mAChR III are coupled effi- 
ciently with phosphoinositide hydrolysis [ 1 l- 131, 
intracellular Ca2+ release [14], activation of 
Ca2+-dependent K+ currents [ 11,14,15] and inhibi- 
tion of the M current [l 11, whereas mAChR II and 
mAChR IV are linked preferentially with 
adenylate cyclase inhibition [ 12,161. 
In the present investigation, we have examined 
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the functional properties of mAChR III and 
mAChR IV expressed in Xenopus oocytes. The 
results obtained show that mAChR III and 
mAChR IV mediate current responses similar to 
those induced by mAChR I and mAChR II, 
respectively. Furthermore, expression studies in 
Xenopus oocytes and in NG 108-I 5 neuroblastoma- 
glioma hybrid cells reveal that the sensitivity to and 
the binding affinity for agonist of mAChR III are 
about one order of magnitude higher than those of 
mAChR I. 
2. MATERIALS AND METHODS 
mRNAs specific for porcine mAChR I, porcine mAChR III, 
rat mAChR III and rat mAChR IV were synthesized by 
transcription in vitro of the respective cloned DNAs as in [2,3]. 
Each of the mAChR subtype-specific mRNAs was injected into 
Xenopus laevis oocytes; the mRNA concentration used was 
1 pg/pl for the mAChR I- and mAChR IV-specific mRNAs or 
1 ng/Fl for the mAChR III-specific mRNAs, unless otherwise 
indicated, and the average volume injected per oocyte was 
-40 nl. The injected oocytes were incubated at 19°C for 2 days 
as in [l]. 
Electrophysiological measurements on Xenopus oocytes were 
carried out at 20-24°C in Ringer’s solution under the condi- 
tions described previously [I], unless otherwise specified. The 
Na+-free solution was composed of 120 mM KCl, 1.8 mM 
CaC12 and 10 mM Tris-HCl (pH 7.2), and the Kf-free solution 
of 120 mM NaCl, 1.8 mM CaCl2 and 10 mM Tris-HCl (pH 
7.2). Our detectable limit for acetylcholine (ACh)-activated cur- 
rents was -10 nA. EGTA was injected ionophoretically into 
oocytes as in [2], except that the duration was 10 min. (-)- 
[-‘H]N-methylscopolamine (NMS)-binding activity on the 
oocyte surface was estimated as in [2]. Displacement of (- )- 
[3H]quinuclidinyl benzilate (QNB) binding by unlabelled car- 
bamylcholine was measured using oocyte extracts as in [3]. 
For the assay of inositol phosphate formation, NGlOS-15 
cells transformed to express porcine mAChR I, porcine 
mAChR 111 or rat mAChR III [11] were incubated in Dulbec- 
co’s modified Eagle’s medium (DMEM) supplemented with 
6 &i/ml myo-[3H]inositol (spec. act. 20.0 Ci/mmol) at 37°C 
for 2.5 h and then in DMEM without [‘Hlinositol for 1 h. After 
preincubation in DMEM containing 10 mM LiCl at 37’C for 
5 min, the labelled cells were stimulated by various concentra- 
tions (10 nM to 1 mM) of carbamylcholine at 37°C for 10 min. 
Control cells were incubated without carbamylcholine. Total 
inositol phosphates were extracted [17], isolated [18] and 
counted for radioactivity. 
3. RESULTS AND DISCUSSION 
Porcine and rat mAChR III and rat mAChR IV 
were expressed in Xenopus oocytes by microinjec- 
tion of the respective subtype-specific mRNAs 
derived from the cloned DNAs. The ( -)- 
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[3H]NMS-binding activity on the cell surface per 
oocyte was 1.2 + 0.2 fmol (mean * SD, n = 3) for 
porcine mAChR III, 1.5 + 1.4 fmol (n = 3) for rat 
mAChR III and 65 f 13 fmol (n = 3) for rat 
mAChR IV; note that the concentrations of the 
mAChR III- and mAChR IV-specific mRNAs in- 
jected were 1 ng/pl and 1 pg/,ul, respectively. All 
the injected oocytes showed a current response to 
ACh. At -70 mV membrane potential, the peak 
inward current elicited by 10 nM ACh was 1.53 + 
0.47 PA (n = 20) for porcine mAChR III and 1.41 
* 0.35 ,uA (n = 20) for rat mAChR III (see also 
fig.3). These currents were much larger than the 
peak inward current activated by 1 PM ACh in 
oocytes implanted with rat mAChR IV (166 + 
72 nA, n = 30). No detectable response to ACh 
(1 PM) was observed in 20 noninjected oocytes. 
The ACh response observed in oocytes implanted 
with either mAChR species was abolished by 
atropine or (-)-scopolamine (0.1 PM each) in a 
reversible manner, whereas ( + )-tubocurarine 
(2.5 PM) and cr-bungarotoxin (0.1 PM) exerted no 
effect. 
The ACh-activated inward current observed in 
mAChR III-implanted oocytes was oscillatory in 
nature (fig.lA, a), whereas mAChR IV-implanted 
oocytes typically showed a response comprising an 
initial smooth inward current followed by an 
oscillatory component (fig. lB, a). Application of 
hyperpolarizing test pulses indicated that these in- 
ward currents were accompanied by increased 
membrane conductance. The oscillatory current 
evoked by mAChR IV varied in amplitude among 
the oocytes tested and was undetected in some of 
them. The latency of the ACh response in mAChR 
IV-implanted oocytes was shorter than that in 
mAChR III-implanted oocytes, the former being 
mostly attributable to the dead-space time in the 
perfusion system (-7 s). The current response in 
mAChR III-implanted oocytes occurred after an 
additional delay (2 f 1 s, n = IO). Replacement of 
extracellular Ca2’ by Mg2+ did not significantly af- 
fect the ACh response in oocytes implanted with 
either mAChR III or mAChR IV. However, in- 
tracellular injection of the calcium-chelating agent 
EGTA almost completely abolished the ACh- 
activated current in mAChR III-implanted oocytes 
(fig.lA, b), leaving only a small long-lasting in- 
ward current (32 + 10 nA in amplitude and 8 + 
2 min in duration, n = 8, no detectable current be- 
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Fig.1. Effect of EGTA on ACh-activated currents in Xenopus 
oocytes injected with the porcine mAChR III-specific mRNA 
(A) or the rat mAChR IV-specific mRNA (B). Whole-cell 
currents activated by bath application of 10 nM (A) or 1 PM 
ACh (B) were recorded under voltage clamp at -70 mV 
membrane potential before (a) and after (b) intracellular 
injection of EGTA. Inward current is downward. The duration 
of ACh application is indicated by bars without taking into 
account the dead-space time in the perfusion system (-7 s). The 
ACh response in oocytes injected with the rat mAChR III- 
specific mRNA was similar to that in oocytes injected with the 
porcine mAChR III-specific mRNA. 
ing observed in 2 of the 10 oocytes tested). The 
oscillatory current in mAChR IV-implanted 
oocytes similarly disappeared after this treatment, 
whereas the smooth current was virtually unaf- 
fected (fig.lB, b). 
Fig.2 shows the ACh-activated currents record- 
ed from an oocyte implanted with mAChR III (A) 
or mAChR IV (B) at various membrane potentials. 
The reversal potential of the oscillatory current 
elicited by mAChR III in Ringer’s solution was 
-26 + 2 mV (n = 13), which is close to the 
equilibrium potential of chloride ions in Xenopus 
oocytes [19]. In fact, the reversal potential shifted 
by 16 f 1 mV (n = 3) to a more positive value when 
the external Cl- concentration was halved by 
substitution with SO:-. The oscillatory current in 
mAChR IV-implanted oocytes was reversed in 
polarity at a potential around -25 mV, whereas 
the reversal potential of the smooth current was 
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Fig.2. Membrane-potential dependence of ACh-activated 
currents in Xenopus oocytes injected with the porcine mAChR 
III-specific mRNA (A) or the rat mAChR IV-specific mRNA 
(B). Whole-cell currents activated by bath application of 10 nM 
(A) or 1 PM ACh (B) were recorded under voltage clamp at 
different membrane potentials (mV) as indicated on the Ieft- 
hand side of each trace. Inward current is downward. The 
duration of ACh application is indicated as in fig.1. The 
membrane-potential dependence of ACh-activated currents in 
oocytes injected with the rat mAChR III-specific mRNA was 
similar to that in oocytes injected with the porcine mAChR III- 
specific mRNA. 
around 10 mV. In mAChR IV-implanted oocytes 
loaded with EGTA, the reversal potential of the 
smooth current in Ringer’s solution was 11 f 2 mV 
(n = 13) and was virtually unchanged even when 
external Cl- was completely replaced by SO:-. In 
a K+-free solution (120 mM Na+), the reversal 
potential of the smooth current was 11 f 2 mV (n 
= 3) and shifted to - 1 + 2 mV (n = 3) when the 
Na+ concentration was reduced to one half by 
substitution with Tris. The reversal potential in a 
Na+-free solution (120 mM K+) was - 2 -+ 2 mV 
(n = 3) and changed to - 16 + 2 mV (n = 3) when 
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the K+ concentration was halved by substitution 
with Tris. These results indicate that mAChR Ill, 
like mAChR 1, mediates activation of a 
Ca*+-dependent Cl- current, whereas mAChR IV, 
like mAChR 11, principally induces activation of 
Na+ and K+ currents in a Ca*+-independent 
manner. 
Fig.3 shows dose-response relationships for 
ACh-activated peak inward currents obtained 
from oocytes implanted with mAChR 1 (circles) or 
mAChR Ill (squares). It is to be noted that the 
concentrations of the mAChR I- and mAChR lll- 
specific mRNAs injected were 1 pg/,ul and 1 ng/,ul, 
respectively. Under these conditions, the receptor 
density on the cell surface, as estimated by (-)- 
[3H]NMS binding, was comparable for mAChR l- 
implanted oocytes (1.9 * 0.5 fmol/oocyte, n = 3) 
and mAChR III-implanted oocytes (see above). 
Nevertheless, the dose-response curves for 
mAChR I and mAChR III were different. mAChR 
Ill-implanted oocytes responded clearly to 1 nM 
ACh (59 + 35 nA, n = 10, for porcine and 51 f 
26 nA, n = 10, for rat), whereas mAChR l- 
implanted oocytes showed no detectable response 
to 10 nM ACh. To elicit a current of similar 
amplitude, mAChR 1 required a -30-fold higher 
concentration of ACh than did mAChR Ill. When 
oocytes were injected with increasing concentra- 
tions of the porcine mAChR Ill-specific mRNA 
(1 ng/pl to 1 pg/pl), the ( -)-[3H]NMS-binding ac- 
tivity on the cell surface increased from 1.2 to 
90 fmol/oocyte, but the current response to ACh 
(1 nM and 10 nM) was not appreciably 
augmented. 
We further examined whether mAChR 1 and 
mAChR Ill expressed in mammalian cells also dif- 
fered in sensitivity to agonist. Our previous study 
has revealed that mAChR 1 and mAChR Ill, but 
not mAChR 11 and mAChR IV, efficiently mediate 
phosphoinositide hydrolysis in NG108-15 cells 
[ 111. Fig.4 shows the effects of increasing concen- 
trations of carbamylcholine on the formation of 
total [3H]inositol phosphates in NG108-15 cells ex- 
pressing mAChR I (circles) or mAChR Ill 
(squares). The ECso value for mAChR III- 
transformed cells (2.9-3.8 PM) was 7-9-fold 
smaller than that for mAChR l-transformed cells 
(27 PM), although the ( - )-[3H]QNB-binding ac- 
tivities of the two types of cells were comparable 
[I 11. 
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Fig.3. Dose-response curves for ACh-activated peak inward 
currents in Xenopus oocytes injected with the mRNA specific 
for porcine mAChR I (0), porcine mAChR III (0) or rat 
mAChR III (m). Each point represents the mean f SD of 
measurements on 10 oocytes at - 70 mV membrane potential. 
The agonist binding affinities of mAChR 1 and 
mAChR Ill were examined using oocyte extracts 
(fig.5). The apparent dissociation constant (&) for 
carbamylcholine, obtained by measuring displace- 
ment of (-)-[3H]QNB binding, was 7-lo-fold 
lower for mAChR Ill (61-78 PM) than for 
mAChR 1 (580pM); mAChR 1 and mAChR Ill 
have similar & values for ( -)-[3H]QNB [3]. The 
presence of 100 PM guanosine 5 ‘-v,y-imido)tri- 
phosphate (GppNHp) did not appreciably affect 
the extents of displacement by carbamylcholine of 
( -)-[3H]QNB binding to mAChR 1 and mAChR 
Ill. This may indicate that the proportion of high- 
affinity sites is low and that the & values obtained 
represent hose of low-affinity sites [21]. 
The present investigation reveals that mAChR 
Ill has a sensitivity to agonist of about one order 
of magnitude higher than that of mAChR 1 in 
mediating activation of a Ca*+-dependent Cl- cur- 
rent in Xenopus oocytes and in stimulating 
phosphoinositide hydrolysis in NG108-15 cells. In 
accord with this finding is the observation that 
mAChR 111, as compared with mAChR 1, has a 
higher sensitivity to ACh in mediating an increase 
in the concentration of free intracellular Ca*+ in 
NG 108-l 5 cells [ 141. The present study also shows 
that the agonist-binding affinity of mAChR Ill is 
about one order of magnitude higher than that of 
mAChR 1. The higher sensitivity to agonist of 
mAChR III is probably attributable, at least part- 
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Fig.4. Dose-response curves for the formation of total 
[-‘H]inositol phosphates in transformed NGlOS-15 cells with 
porcine mAChR I (clone NGPMl-8; 0), porcine mAChR III 
(clone NGPM3-332; q I) or rat mAChR III (clone NGRM3-309; 
n ). Data are expressed as percentage of the maximum response 
obtained with 1 mM carbamylcholine. Each point represents 
the mean f SD of 3-4 experiments. The formation of total 
[3H]inositol phosphates in cells stimulated by incubation with 
1 mM carbamylcholine, expressed as ratio to that in control 
cells incubated without carbamylcholine, was 3.7 f 0.5 (n = 4), 
4.5 + 0.5 (n = 4) and 4.7 f 0.2 (n = 3) for porcine mAChR I-, 
porcine mAChR III- and rat mAChR III-transformed cells, 
respectively. The theoretical curves have been drawn by 
nonlinear least-square analysis according to the equation y = 
X/(X + ECHO), where x represents the carbamylcholine 
concentration. 
ly, to its higher agonist-binding affinity. It has 
been reported that muscarinic agonists are more 
potent in stimulating phosphoinositide hydrolysis 
in parotid gland than in cerebrum [22,23]. The 
presence of both mAChR I and mAChR III in ex- 
ocrine glands and in cerebrum is suggested by the 
results of hybridization analysis which show that 
the corresponding mRNA species coexist in these 
tissues [1,8-lo]. The EC50 value of car- 
bamylcholine in stimulating phosphoinositide 
hydrolysis in the parotid gland (2.6-10.5 ,uM 
[22,23]) is comparable to that in mAChR III- 
transformed NG108-15 cells (2.9-3.8 pM), 
whereas a similar correlation is found between the 
EC50 values for cerebrum (43-68 pM [22,23]) and 
mAChR I-transformed NG108-15 cells (27 PM). 
Thus, it seems that mAChR III predominantly 
contributes to the response in the parotid gland, 
whereas mAChR I is mainly involved in ‘the 
response in cerebrum. The mechanism underlying 
the preferential involvement of the individual 
mAChR subtypes in the response in these tissues 
remains to be elucidated. 
[Carbamylcholine] (M) 
Fig.5. Effect of carbamylcholine on (-)-[‘H]QNB binding in 
extracts from Xenopus oocytes injected with the mRNA specific 
for porcine mAChR I (0), porcine mAChR III (0) or rat 
mAChR III (m). The concentration of the porcine and the rat 
mAChR III-specific mRNA injected was 32 ng/& Data are 
from 3 experiments. Values for 100% and 0% binding were 
determined by measurements in the absence of carbamylcholine 
and in the presence of 10~M atropine, respectively. The 0% 
values [43-250 dpm (O), 39-279 dpm (0) or 55-217 dpm (m)] 
were 3-17% (O), l-21% (0) or 3-18070 (m) of the 100% 
values. The theoretical curves have been drawn by nonlinear 
least-square analysis as in [l]. The ICSO value of 
carbamylcholine was 3.67 mM for porcine mAChR I, 371 PM 
for porcine mAChR III and 336 pM for rat mAChR III. The Ka 
values for carbamylcholine were calculated from the ICSO values 
[20], using the & values for (-)-[‘H]QNB taken from [3]. 
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